News & Insights

World Hepatitis Day, observed on July 28, tells a complex and fascinating story about how a scientific discovery can influence public health on a global scale. The date was chosen to coincide with the birthday of Dr. Baruch Blumberg, the scientist who discovered the hepatitis B virus, developed a diagnostic test for the virus, and was a driving force behind the development of the vaccine against it.

The Israeli Supreme Court has rendered its important and controversial decision in the Sanofi v. Unipharm case, holding that a Patent Applicant who intentionally deceives the Patent Office in order to obtain a patent, may be liable, under the Israeli law of unjust enrichment, to pay generic competitors who delayed entering the market at risk because of this patent application, restitution of the profits gained at their expense as a result of this deception.

In the four decades that have passed since the fatal AIDS disease erupted in 1981, considerable efforts were and continue to be invested into developing treatments. This has been largely successful. Today AIDS is no longer a life-threatening disease. The first breakthrough occurred when scientists succeeded in identifying the virus…

World Brain Day 2023 was celebrated on July 22 as an initiative of the World Federation of Neurology (WFN), using the slogan "Brain Health and Disability: Leave No One Behind." Recognizing the importance of the day, we decided to give a platform to a number of trends and pioneering companies in the field and tell about their contribution to the latest developments intended to save lives and improve the quality of life.

November 14 was designated by the United Nations as World Diabetes Day. The prevalence of diabetes has increased dramatically over recent decades and reached a global epidemic level, with major health and health economic consequences worldwide.

The Israeli Parliament (the Knesset) has voted, in a first reading, in favor of a proposed amendment to the Israeli Patents Law (1967) that aims to increase the global competitive advantage of Israeli generic pharmaceutical companies.

The unprecedented success of the COVID-19 vaccines, both therapeutically and commercially, has prompted fierce competition. Multiple companies around the world are fighting to claim patent rights related to these vaccines.

As the New York Times recently reported, ten years have passed since the first publication of a ground-breaking paper about the potential usefulness of CRISPR, “the gene-editing technology [that] has led to innovations in medicine, evolution and agriculture — and raised profound ethical questions about altering human DNA.”